Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 4/2015

01.12.2015 | Original Article

Association of abdominal obesity, hypertriglyceridemia, and hypertriglyceridemic waist phenotype with hypertension and type 2 diabetes mellitus

verfasst von: Surapon Tangvarasittichai, Chintana Seangsuk, Chaiwat Chaisomboon, Suwadee Meemark, Orathai Tangvarasittichai

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

The present study tested the hypothesis that simple variables, such as waist circumference, hypertriglyceridemia (eTG), and hypertriglyceridemic waist (eTGWC) phenotype could be used as screening tools for the identification of those at high risk in hypertension (HT) and type 2 diabetes mellitus (T2DM). Based on data from our health survey, check of 4206 participants (997 men and 3209 women) were 420 (42.1 %) and 2394 (74.6 %) AO men and women, 370 (37.1 %) and 1340 (41.8 %) eTG men and women, and 236 (23.7 %) and 1131 (35.2 %) eTGWC men and women. We demonstrated that AO, eTG, and eTGWC phenotype associated with increased risk of HT and T2DM. In men, the largest area under curve (AUC) of the receiver operating characteristic (ROC) curves demonstrated that AO was the best marker for HT and eTG was the best marker for T2DM in men, while eTGWC was the best marker for both HT and T2DM in women. In conclusion, it is suggested AO may serve as the early phenotype-associated sequel to eTG reach to eTGWC. Waist circumference measurements and fasting triglycerides can serve as inexpensive screening tools for HT and T2DM to identify those at high risk of HT and T2DM.
Literatur
1.
Zurück zum Zitat Okosun IS, Chandra KM, Choi S, Christman J, Dever GE, Prewitt TE. Hypertension and type 2 diabetes comorbidity in adults in the United States: risk of overall and regional adiposity. Obes Res. 2001;9:1–9.CrossRefPubMed Okosun IS, Chandra KM, Choi S, Christman J, Dever GE, Prewitt TE. Hypertension and type 2 diabetes comorbidity in adults in the United States: risk of overall and regional adiposity. Obes Res. 2001;9:1–9.CrossRefPubMed
2.
Zurück zum Zitat Okosun IS, Dever GE. Abdominal obesity and ethnic differences in diabetes awareness, treatment, and glycemic control. Obes Res. 2002;10:1241–50.CrossRefPubMed Okosun IS, Dever GE. Abdominal obesity and ethnic differences in diabetes awareness, treatment, and glycemic control. Obes Res. 2002;10:1241–50.CrossRefPubMed
3.
Zurück zum Zitat Karter AJ, D’Agostino Jr RB, Mayer-Davis EJ, Wagenknecht LE, Hanley AJ, Hamman RF, et al. Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Obes Metab. 2005;7:230–8.CrossRefPubMed Karter AJ, D’Agostino Jr RB, Mayer-Davis EJ, Wagenknecht LE, Hanley AJ, Hamman RF, et al. Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Obes Metab. 2005;7:230–8.CrossRefPubMed
4.
Zurück zum Zitat Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19:708–23.CrossRefPubMed Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19:708–23.CrossRefPubMed
5.
Zurück zum Zitat Alberti KG, Zimmet P, Shaw J, IDF epidemiology task force consensus group. The metabolic syndrome- a new worldwide definition. Lancet. 2005;366:1059–62.CrossRefPubMed Alberti KG, Zimmet P, Shaw J, IDF epidemiology task force consensus group. The metabolic syndrome- a new worldwide definition. Lancet. 2005;366:1059–62.CrossRefPubMed
6.
Zurück zum Zitat Despres JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition. 1993;9:452–9.PubMed Despres JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition. 1993;9:452–9.PubMed
7.
Zurück zum Zitat Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7B–12B.CrossRefPubMed Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7B–12B.CrossRefPubMed
8.
Zurück zum Zitat Coughlan BJ, Sorrentino MJ. Does hypertriglyceridemia increase risk for CAD? Growing evidence suggests it plays a role. Postgrad Med J. 2000;108:77–84. Coughlan BJ, Sorrentino MJ. Does hypertriglyceridemia increase risk for CAD? Growing evidence suggests it plays a role. Postgrad Med J. 2000;108:77–84.
9.
Zurück zum Zitat Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309–16.CrossRefPubMed Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309–16.CrossRefPubMed
10.
Zurück zum Zitat Ferroni P, Basili S, Falco A, Davi G. Inflammation, insulin resistance, and obesity. Curr Atheroscler Rep. 2004;6:424–31.CrossRefPubMed Ferroni P, Basili S, Falco A, Davi G. Inflammation, insulin resistance, and obesity. Curr Atheroscler Rep. 2004;6:424–31.CrossRefPubMed
11.
Zurück zum Zitat Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548–56.CrossRefPubMed Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548–56.CrossRefPubMed
12.
Zurück zum Zitat St-Pierre J, Lemieux I, Perron P, Brisson D, Santure M, Vohl MC, et al. Relation of the “hypertriglyceridemic waist” phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J Cardiol. 2007;99:369–73.CrossRefPubMed St-Pierre J, Lemieux I, Perron P, Brisson D, Santure M, Vohl MC, et al. Relation of the “hypertriglyceridemic waist” phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J Cardiol. 2007;99:369–73.CrossRefPubMed
13.
Zurück zum Zitat Gazi IF, Filippatos TD, Tsimihodimos V, Saougos VG, Liberopoulos EN, Mikhailidis DP, et al. The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol. Lipids. 2006;41:647–54.CrossRefPubMed Gazi IF, Filippatos TD, Tsimihodimos V, Saougos VG, Liberopoulos EN, Mikhailidis DP, et al. The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol. Lipids. 2006;41:647–54.CrossRefPubMed
14.
Zurück zum Zitat Okosun IS, Boltri JM. Abdominal obesity, hypertriglyceridemia, hypertriglyceridemic waist phenotype and risk of type 2 diabetes in American adults. Diabetes Metab Syndr Clin Res Rev. 2008;2:273–81.CrossRef Okosun IS, Boltri JM. Abdominal obesity, hypertriglyceridemia, hypertriglyceridemic waist phenotype and risk of type 2 diabetes in American adults. Diabetes Metab Syndr Clin Res Rev. 2008;2:273–81.CrossRef
15.
Zurück zum Zitat Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.CrossRefPubMed Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.CrossRefPubMed
16.
Zurück zum Zitat Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102:179–84.CrossRefPubMed Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102:179–84.CrossRefPubMed
17.
Zurück zum Zitat Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65–85.CrossRefPubMed Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65–85.CrossRefPubMed
18.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Coordinating Committee. Hypertension. 2003;42:1206–52.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Coordinating Committee. Hypertension. 2003;42:1206–52.CrossRefPubMed
20.
Zurück zum Zitat NCEP Expert Panel. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef NCEP Expert Panel. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef
21.
Zurück zum Zitat Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.CrossRefPubMed Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.CrossRefPubMed
22.
Zurück zum Zitat Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460–8.CrossRefPubMed Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460–8.CrossRefPubMed
23.
Zurück zum Zitat Diamant M, Lamb HJ, van de Ree MA, Endert EL, Groeneveld Y, Bots ML, et al. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab. 2005;90:1495–501.CrossRefPubMed Diamant M, Lamb HJ, van de Ree MA, Endert EL, Groeneveld Y, Bots ML, et al. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab. 2005;90:1495–501.CrossRefPubMed
24.
Zurück zum Zitat Anjana M, Sandeep S, Deepa R, Vimaleswaran KS, Farooq S, Mohan V. Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians. Diabetes Care. 2004;27:2948–53.CrossRefPubMed Anjana M, Sandeep S, Deepa R, Vimaleswaran KS, Farooq S, Mohan V. Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians. Diabetes Care. 2004;27:2948–53.CrossRefPubMed
25.
26.
Zurück zum Zitat Villegas R, Liu S, Gao YT, Yang G, Li H, Zheng W, et al. Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch Intern Med. 2007;167:2310–6.CrossRefPubMed Villegas R, Liu S, Gao YT, Yang G, Li H, Zheng W, et al. Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch Intern Med. 2007;167:2310–6.CrossRefPubMed
27.
Zurück zum Zitat Daskalopoulou SS, Mikhailidis DP, Elisaf M. Prevention and treatment of the metabolic syndrome. Angiology. 2004;55:589–612.CrossRefPubMed Daskalopoulou SS, Mikhailidis DP, Elisaf M. Prevention and treatment of the metabolic syndrome. Angiology. 2004;55:589–612.CrossRefPubMed
Metadaten
Titel
Association of abdominal obesity, hypertriglyceridemia, and hypertriglyceridemic waist phenotype with hypertension and type 2 diabetes mellitus
verfasst von
Surapon Tangvarasittichai
Chintana Seangsuk
Chaiwat Chaisomboon
Suwadee Meemark
Orathai Tangvarasittichai
Publikationsdatum
01.12.2015
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 4/2015
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-015-0302-7

Weitere Artikel der Ausgabe 4/2015

International Journal of Diabetes in Developing Countries 4/2015 Zur Ausgabe